OpenAI

OpenAI actively seeks legal protection for innovations while building tech using copyrighted materials, highlighting contradictions in AI's intellectual property landscape.

Legal fights: Musk seeks injunction on OpenAI-Microsoft deals; Canadian media claims 16.1M works used without permission for AI training

OpenAI CEO Altman's role as co-chair signals tech-driven approaches to municipal challenges, potentially bringing innovation to governance.

OpenAI partners with Sanofi, Simplon, Mirakl & ESCP in France, focusing on clinical trials, education, marketplace growth & personalised learning.

Company created 240 custom GPTs in 10 weeks, including specialised tools for fragrance analysis and clinical trials, achieving 90% faster response times.

Models combining web search with LLMs outperformed standalone models on SimpleQA. Real-time data access proved crucial for factual accuracy.